IBDEI1PT ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30744,0)
 ;;=N52.2^^189^1922^14
 ;;^UTILITY(U,$J,358.3,30744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30744,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,30744,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,30744,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,30745,0)
 ;;=N52.02^^189^1922^13
 ;;^UTILITY(U,$J,358.3,30745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30745,1,3,0)
 ;;=3^Erectile Dysfunction,Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,30745,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,30745,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,30746,0)
 ;;=N52.03^^189^1922^12
 ;;^UTILITY(U,$J,358.3,30746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30746,1,3,0)
 ;;=3^Erectile Dysfunction,Artrl Insuff/Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,30746,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,30746,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,30747,0)
 ;;=N52.1^^189^1922^18
 ;;^UTILITY(U,$J,358.3,30747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30747,1,3,0)
 ;;=3^Eriectile Dysfunction d/t Oth Diseases
 ;;^UTILITY(U,$J,358.3,30747,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,30747,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,30748,0)
 ;;=N52.01^^189^1922^17
 ;;^UTILITY(U,$J,358.3,30748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30748,1,3,0)
 ;;=3^Eriectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,30748,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,30748,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,30749,0)
 ;;=R33.9^^189^1922^35
 ;;^UTILITY(U,$J,358.3,30749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30749,1,3,0)
 ;;=3^Retention of Urine,Unspec
 ;;^UTILITY(U,$J,358.3,30749,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,30749,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,30750,0)
 ;;=R32.^^189^1922^39
 ;;^UTILITY(U,$J,358.3,30750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30750,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,30750,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,30750,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,30751,0)
 ;;=R35.0^^189^1922^19
 ;;^UTILITY(U,$J,358.3,30751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30751,1,3,0)
 ;;=3^Frequency of Micturition
 ;;^UTILITY(U,$J,358.3,30751,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,30751,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,30752,0)
 ;;=I83.019^^189^1923^21
 ;;^UTILITY(U,$J,358.3,30752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30752,1,3,0)
 ;;=3^Varicose Veins of Right Lower Extremity w/ Ulcer
 ;;^UTILITY(U,$J,358.3,30752,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,30752,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,30753,0)
 ;;=I83.029^^189^1923^12
 ;;^UTILITY(U,$J,358.3,30753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30753,1,3,0)
 ;;=3^Varicose Veins of Left Lower Extremity w/ Ulcer
 ;;^UTILITY(U,$J,358.3,30753,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,30753,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,30754,0)
 ;;=I83.014^^189^1923^13
 ;;^UTILITY(U,$J,358.3,30754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30754,1,3,0)
 ;;=3^Varicose Veins of Right Lower Extrem w/ Heel/Midfoot Ulcer
 ;;^UTILITY(U,$J,358.3,30754,1,4,0)
 ;;=4^I83.014
 ;;^UTILITY(U,$J,358.3,30754,2)
 ;;=^5007976
 ;;^UTILITY(U,$J,358.3,30755,0)
 ;;=I83.013^^189^1923^14
 ;;^UTILITY(U,$J,358.3,30755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30755,1,3,0)
 ;;=3^Varicose Veins of Right Lower Extrem w/ Ankle Ulcer
 ;;^UTILITY(U,$J,358.3,30755,1,4,0)
 ;;=4^I83.013
 ;;^UTILITY(U,$J,358.3,30755,2)
 ;;=^5007975
 ;;^UTILITY(U,$J,358.3,30756,0)
 ;;=I83.012^^189^1923^15
 ;;^UTILITY(U,$J,358.3,30756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30756,1,3,0)
 ;;=3^Varicose Veins of Right Lower Extrem w/ Calf Ulcer
